Government of Jersey

Prescription of drugs to patients (FOI)

Produced by the Freedom of Information office
Authored by Government of Jersey and published on 06 April 2023.
Prepared internally, no external costs.

Request

How many patients has your trust and or health board treated in the past six months (for any disease) with the following drugs:

Aubagio (teriflunomide)
Avonex (interferon beta-1a)
Betaferon (interferon beta-1b)
Brabio (glatiramer acetate)
Copaxone (glatiramer acetate)
Extavia (beta interferon-1b)
Gilenya (fingolimod)
Lemtrada (alemtuzumab)
Kesimpta (ofatumumab)
Mavenclad (cladribine)
Mayzent (siponimod)
Ocrevus (ocrelizumab)
Plegridy (peginterferon beta-1a)
Ponvory (ponesimod)
Rebif (beta interferon-1a)
Tecfidera (dimethyl fumarate)
Tysabri (natalizumab)
Tysabri (natalizumab) pre-filled syringes ONLY
Vumerity (diroximel fumarate)
Zeposia (ozanimod)

Response

Data for the specified medications is detailed in the table below. Where a drug from the list does not appear in the table, no patients have been prescribed this medication in the past six months.

Drug name and formulation / route of administration	Number of patients prescribed
Alemtuzumab - Infusion	1
Dimethyl fumarate (Tecfidera) - 120 mg Capsules	2
Dimethyl fumarate (Tecfidera) - 240 mg Capsules	6
Fingolimod - 500 micrograms Capsules	1
Glatiramer – 40 mg Injection	1
Interferon beta-1a (Avonex) (6 million units) – 30 micrograms	1
Natalizumab – 150 mg in 1ml Injection	8
Natalizumab – 300 mg in 15ml Infusion	3
Ocrelizumab – 300 mg in 10ml Injection	10
Ofatumumab – 20 mg in 0.4ml Pre-filled Pen	9
Peginterferon beta-1a - 125 micrograms in 0.5ml Injection	1
Siponimod – 2 mg Tablets	2
Teriflunomide – 14 mg Tablets	2